How to Get Losartan in Maryland

What Losartan Is and Why Maryland Clinicians Prescribe It

Losartan (brand name Cozaar, now widely available as generic) is an angiotensin II receptor blocker approved by the FDA for three distinct indications: hypertension, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, and nephropathy in patients with type 2 diabetes and an elevated serum creatinine. [1] It was the first ARB approved in the United States, receiving initial FDA clearance in 1995.

The LIFE trial (Lancet 2002, N=9,193) compared losartan 50 to 100 mg daily against atenolol 50 to 100 mg daily in hypertensive patients with electrocardiographic left ventricular hypertrophy. [2] Losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (P<0.001), driven almost entirely by a 25% reduction in fatal and non-fatal stroke. That single trial is why the American Heart Association hypertension guidelines specifically list ARBs as preferred agents for hypertensive patients with LVH. [3]

Maryland has a hypertension prevalence of approximately 34% among adults, slightly above the national average of 32%, according to CDC state-level surveillance data. [4] That translates to roughly 1.5 million Marylanders who could qualify for ARB therapy. Losartan's generic price and once-daily dosing make it one of the most frequently written antihypertensives in the state.

For diabetic nephropathy, the RENAAL trial (N=1,513) demonstrated that losartan 100 mg daily reduced the primary composite of doubling of serum creatinine, end-stage renal disease, or death by 16% versus placebo (P=0.02) in patients with type 2 diabetes and overt nephropathy. [5] The American Diabetes Association's Standards of Medical Care recommends ACE inhibitors or ARBs as first-line agents for diabetic kidney disease, citing RENAAL among the foundational evidence. [6]

Who Can Prescribe Losartan in Maryland

Any Maryland-licensed prescriber with Schedule II through V DEA registration can write a losartan prescription, though because losartan is non-controlled, DEA registration is not actually required. Eligible prescribers include:

Physicians (MD or DO). Full prescriptive authority. Maryland-licensed physicians may prescribe losartan for any FDA-approved or clinically supported off-label indication without a collaborative practice agreement.

Nurse practitioners (CRNP). Maryland CRNPs who have completed their required period of supervision now practice with full independent prescriptive authority under Maryland Code, Health Occupations Article §8-601. [7] They may prescribe losartan independently.

Physician assistants (PA). Maryland PAs prescribe under a written delegation agreement with a supervising physician. [8] That agreement must list the drug categories the PA may prescribe; antihypertensives are almost universally included.

Certified nurse midwives (CNM) and clinical nurse specialists (CNS). These practitioners may also prescribe losartan within their scope when hypertension is relevant to patient care, for example, chronic hypertension in pregnancy (though alternative ARBs are typically avoided in pregnancy due to teratogenicity, and losartan carries an FDA black-box warning for fetal toxicity). [1]

The practical upshot: Maryland patients have many prescriber types available, including online prescribers, without needing to see a cardiologist or nephrologist for routine hypertension management.

Getting a Losartan Prescription In Person in Maryland

The most straightforward path is a primary care appointment. During a standard new-patient or established-patient visit, a clinician will:

1. Confirm elevated blood pressure on at least two separate readings (the 2017 ACC/AHA guideline defines stage 1 hypertension as systolic 130 to 139 mmHg or diastolic 80 to 89 mmHg). [3]
2. Order or review baseline labs (BMP for potassium, creatinine, and eGFR; urinalysis for proteinuria if diabetic nephropathy is suspected).
3. Assess for contraindications, primarily pregnancy, bilateral renal artery stenosis, and concurrent aliskiren use in diabetics (the latter combination is contraindicated per FDA labeling). [1]
4. Write a prescription for losartan 50 mg once daily as a starting dose in most patients, or 25 mg for those with hepatic impairment or significant volume depletion.

Maryland's primary care network includes community health centers funded through HRSA that operate on sliding-fee schedules for uninsured patients. [9] Finding one near Baltimore, Annapolis, or any Maryland county seat is possible through the HRSA Find a Health Center tool.

Getting a Losartan Prescription via Telehealth in Maryland

Maryland law explicitly permits telehealth prescribing of non-controlled substances. The Maryland telehealth statute (Md. Code Ann., Health-Gen. §19-141) allows a valid prescriber-patient relationship to be established via synchronous audio-video communication, meaning no prior in-person visit is legally required before a telehealth clinician prescribes losartan. [10]

Telehealth platforms operating in Maryland typically follow this sequence:

• The patient completes an intake form covering medical history, current medications, and blood pressure readings (home cuff or recent in-office measurement).
• A licensed Maryland prescriber conducts a synchronous video visit, typically 15 to 20 minutes.
• If labs are needed, an e-order is sent to a Maryland LabCorp or Quest draw site, or the patient submits recent results.
• The prescription is sent electronically to a pharmacy of the patient's choice, including mail-order pharmacies licensed in Maryland.

The HealthRX clinical team uses the following three-stage telehealth eligibility framework for losartan prescribing in Maryland:

Stage 1 (Straightforward). Patient has documented hypertension, no diabetes, no CKD, eGFR >60 mL/min/1.73m², potassium <5.0 mEq/L, and no pregnancy. Losartan 50 mg daily can be initiated at the index telehealth visit with a follow-up potassium and creatinine check at 2 to 4 weeks.

Stage 2 (Lab-first). Patient has type 2 diabetes, eGFR 30 to 60 mL/min/1.73m², or a baseline potassium of 5.0 to 5.4 mEq/L. Labs are ordered before prescribing. Telehealth visit is scheduled after results are reviewed, typically 3 to 5 business days.

Stage 3 (Refer to in-person). Patient has eGFR <30 mL/min/1.73m², potassium >5.4 mEq/L, suspected bilateral renal artery stenosis, or is pregnant. In-person nephrology or maternal-fetal medicine evaluation is required before an ARB is started.

This framework aligns with the KDIGO 2024 guidelines on CKD management, which set an eGFR of 30 mL/min/1.73m² as the threshold below which ARB initiation requires specialist input. [11]

Labs Required Before Starting Losartan in Maryland

A basic metabolic panel (BMP) is the minimum required before starting losartan. The two values that determine safety are serum potassium (hyperkalemia risk, especially with CKD or concurrent potassium-sparing diuretics) and serum creatinine with eGFR (to detect existing renal impairment and establish a baseline for monitoring). [12]

Additional labs depend on clinical context:

• HbA1c if diabetes is suspected or known, to inform diabetic nephropathy risk.
• Urine albumin-to-creatinine ratio (UACR) if diabetic nephropathy protection is the indication. The ADA recommends annual UACR screening for all patients with type 2 diabetes. [6]
• Liver function tests if hepatic impairment is suspected, since losartan is hepatically metabolized via CYP2C9 and the starting dose should be halved in hepatic impairment. [1]
• Serum sodium in patients on diuretics, as hyponatremia increases the risk of first-dose hypotension.

After starting losartan, the standard monitoring protocol calls for a repeat BMP at 1 to 2 weeks for high-risk patients (CKD, diabetes, concurrent ACE inhibitor in select protocols) and at 4 weeks for lower-risk patients. The KDIGO CKD guideline recommends rechecking serum creatinine and potassium 2 to 4 weeks after any ARB initiation or dose increase. [11]

Acute rises in creatinine of up to 30% above baseline after starting an ARB are generally acceptable and expected because of the drug's hemodynamic effect on glomerular efferent arterioles. A rise exceeding 30% should prompt holding the drug and evaluating for renal artery stenosis. [12]

Maryland Medicaid and Insurance Coverage for Losartan

Maryland Medicaid (administered through HealthChoice managed care organizations) lists losartan on its preferred drug list for hypertension and diabetic nephropathy. Coverage requires prior authorization for some MCOs when the patient does not have an established diagnosis code on file. [13]

Prior authorization for losartan under Maryland Medicaid typically requires:

1. A qualifying ICD-10 diagnosis code: I10 (essential hypertension), I50.x (heart failure), or N08 (glomerular disorders in diseases classified elsewhere, used for diabetic nephropathy).
2. Documentation that first-line therapy such as a thiazide diuretic or ACE inhibitor was either tried and not tolerated, or is contraindicated. ACE inhibitor intolerance due to cough is the most common documented reason for ARB use.
3. A prescriber attestation, often completed by clinical staff via the MCO's online portal.

For commercially insured Maryland residents, losartan 50 mg and 100 mg are almost universally on Tier 1 (generic) of formularies, with copays typically under $15 per month. GoodRx and similar discount programs bring the cash price at major Maryland chains (CVS, Walgreens, Rite Aid, Giant Food Pharmacy) to $9 to $14 for a 30-day supply of 50 mg tablets.

The JNC 8 guideline panel, though a 2014 document now largely superseded for specific targets by the 2017 ACC/AHA guideline, stated directly: "For the general nonblack population, including those with diabetes, initial antihypertensive treatment should include a thiazide-type diuretic, calcium channel blocker, ACE inhibitor, or ARB." [14] That language remains the backbone of most formulary criteria for ARB access.

How Long It Takes to Receive Losartan in Maryland

Timeline varies by channel:

In-person visit, local pharmacy. Same day. The prescriber sends an e-prescription; the patient picks it up within 1 to 4 hours. Most Maryland retail pharmacies stock generic losartan in 25 mg, 50 mg, and 100 mg tablets.

Telehealth visit, local pharmacy. Same day to 24 hours. After the video visit, the e-prescription is sent immediately. If labs are required first, add 1 to 3 business days for results.

Telehealth visit, mail-order pharmacy. 3 to 5 business days for standard shipping. Maryland residents using CVS Caremark, Express Scripts, or OptumRx mail-order programs typically receive a 90-day supply within 5 business days of prescription transmission.

Prior authorization cases. Maryland MCOs are required by state regulation to respond to non-urgent prior authorization requests within 72 hours of receiving a complete submission. Urgent PA requests must be resolved within 24 hours. [13] A complete submission includes the diagnosis codes, clinical notes, and prescriber contact information.

New patient, no prior labs. If a telehealth provider requires labs before prescribing, the timeline extends to 5 to 7 days: 1 day to schedule the lab draw, 1 to 2 days for results, then the video visit and same-day e-prescription.

Transferring an Existing Losartan Prescription to Maryland

Patients moving to Maryland from another state, or snowbirds splitting time between Maryland and another state, can transfer an existing losartan prescription to a Maryland pharmacy. Federal and Maryland pharmacy law allow transfer of non-controlled substance prescriptions between pharmacies with remaining refills. [15]

The practical steps are:

1. Call or visit a Maryland pharmacy and provide the name, address, and phone number of the out-of-state pharmacy where the prescription is on file.
2. The Maryland pharmacist contacts the originating pharmacy to transfer the remaining refills. This typically takes 15 to 30 minutes.
3. If the out-of-state prescription has no remaining refills, the patient needs a new prescription from a Maryland-licensed prescriber. Telehealth is the fastest route.

One nuance: some mail-order pharmacies are already licensed to ship to Maryland and may continue filling a prescription regardless of the patient's location, provided the prescribing clinician holds an active license. NABP's database of state-licensed pharmacies is the authoritative resource for verifying a pharmacy's Maryland dispensing license. [15]

503A Compounded Losartan in Maryland

Maryland-licensed 503A pharmacies can compound losartan preparations for individual patients when a commercially available product does not meet that patient's clinical needs. Common reasons include:

• Pediatric dosing requiring a suspension rather than a tablet (commercial losartan is available as a powder for oral suspension, but stock shortages or cost may make a compounded version preferable).
• Combination formulations not commercially available, such as losartan plus amlodipine at a non-standard ratio.
• Documented allergy to an inactive ingredient in the commercial tablet.

503A compounded losartan is not interchangeable with FDA-approved losartan and is produced patient-by-patient rather than in bulk. The Maryland Board of Pharmacy regulates 503A facilities in the state. [16] A valid patient-specific prescription from a Maryland-licensed prescriber is required; a 503A pharmacy cannot dispense compounded losartan to a patient without one.

The FDA's guidance on compounding distinguishes 503A pharmacies (patient-specific, state-regulated) from 503B outsourcing facilities (bulk production, FDA-registered). [17] Losartan is not on the FDA's current 503B drug shortage list, so bulk-compounded losartan from a 503B facility is not routinely available for Maryland patients through standard telehealth channels.

Monitoring and Dose Titration After Starting Losartan

Starting losartan is the beginning, not the end, of the prescribing process. Blood pressure response is typically evident within 3 to 6 weeks of initiating therapy. The 2017 ACC/AHA hypertension guideline recommends a follow-up visit 1 month after initiation to assess response and tolerability. [3]

Dose titration protocol in most Maryland primary care practices:

• Start: losartan 50 mg once daily (25 mg if hepatic impairment or volume depletion).
• If blood pressure remains above goal (for most adults, <130/80 mmHg per ACC/AHA 2017) after 4 weeks, uptitrate to 100 mg once daily.
• If 100 mg monotherapy is insufficient, add a thiazide diuretic (hydrochlorothiazide 12.5 to 25 mg) or a dihydropyridine calcium channel blocker (amlodipine 5 mg). The combination of losartan plus hydrochlorothiazide is available as a fixed-dose tablet (Hyzaar brand, generics widely available).
• A repeat BMP should accompany each dose increase.

In the RENAAL trial, the mean losartan dose achieving nephroprotective benefit was 100 mg daily. [5] Patients with diabetic nephropathy should therefore be titrated to 100 mg if tolerated, even when blood pressure is already at goal, because the renoprotective effect appears partially independent of blood pressure lowering.

The most common adverse effect requiring clinical attention is hyperkalemia. In a 2021 systematic review published in the Journal of the American Society of Nephrology (N=68 trials), ARB use was associated with a 44% higher risk of hyperkalemia compared to placebo (relative risk 1.44 to 95% CI 1.23 to 1.68). [18] Patients with eGFR <45 mL/min/1.73m², those taking potassium-sparing diuretics (spironolactone, eplerenone), or those on trimethoprim-sulfamethoxazole are at highest risk and warrant more frequent electrolyte monitoring.